01 Increasing Focus on Postpartum Depression (PPD) Postpartum depression (PPD) is receiving heightened attention as awareness grows regarding its profound impact on mothers, infants, and even family members. With rising cases of PPD among women, healthcare providers are prioritizing routine screening and early intervention to improve maternal health outcomes. For instance, a study published in NCBI in July 2023 estimated that approximately 10-20% of mothers experience PPD, highlighting it as a significant public well-being concern. Likewise, in October 2022, according to the article published in Postpartum Depression.org, approximately 1 in 10 women will experience postpartum depression after giving birth, with few studies reporting 1 in 7 women. The increasing prevalence of PPD underscores the urgent need for effective management strategies, driving the growth of the global maternal mental health market.
May 2026 Sage Therapeutics expanded its maternal mental health portfolio by advancing clinical development programs targeting postpartum depression and other pregnancy-related mood disorders.
March 2026 Talkspace introduced specialized virtual maternal mental health services, expanding access to licensed therapists and digital behavioral health support for pregnant and postpartum individuals.
October 2025 Canopie expanded its digital maternal mental health platform through new partnerships with healthcare providers and employers, improving access to preventive mental health support during pregnancy and postpartum.
June 2025 Maven Clinic strengthened its women's and family health platform by expanding maternal mental health services, including virtual counseling, psychiatric care, and postpartum support.